Epalrica-M Tablet SR
Prescription Required
Introduction of Epalrica-M Tablet SR
Epalrica-M Tablet SR is a medicine used in the treatment of diabetic nerve disease. It protect the nerve fibers from damage and promotes regeneration of nerve cells. It is used along with other blood sugar lowering medications in order to prevent further nerve injury.
Epalrica-M Tablet SR is a medicine used in the treatment of diabetic nerve disease. It protects the nerve fibers from damage and promotes regeneration of nerve cells. It is used along with other blood sugar lowering medications in order to prevent further nerve injury.
Epalrica-M Tablet SR is a medicine used in the treatment of diabetic nerve disease. It protects the nerve fibers from damage and promotes regeneration of nerve cells. It is used along with other blood sugar lowering medications in order to prevent further nerve injury.
Uses of Epalrica-M Tablet SR
Benefits of Epalrica-M Tablet SR
In Diabetic nerve pain
Epalrica-M Tablet SR is a medicine used to treat long-lasting (chronic) pain caused by nerve damage due to diabetes. It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness. It interferes with pain signals that travel through the damaged nerves and the brain and also improves nerve conduction. Taking Epalrica-M Tablet SR regularly will improve your physical and social functioning and overall quality of life.
Side effects of Epalrica-M Tablet SR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Epalrica-M
- Nausea
- Vomiting
- Increased liver enzymes
How to use Epalrica-M Tablet SR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Epalrica-M Tablet SR may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Epalrica-M Tablet SR.
Pregnancy
CONSULT YOUR DOCTOR
Epalrica-M Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Epalrica-M Tablet SR during breastfeeding is not available. Please consult your doctor.
Driving
CONSULT YOUR DOCTOR
It is not known whether Epalrica-M Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Epalrica-M Tablet SR in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Epalrica-M Tablet SR in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Epalrica-M Tablet SR
βΉ25.21/Tablet SR
Epineuron SR Tablet
Aristo Pharmaceuticals Pvt Ltd
βΉ21.57/tablet sr
14% cheaper
Aldonil Plus Tablet SR
Zydus Cadila
βΉ28.03/tablet sr
11% costlier
Alrista Plus Tablet SR
Macleods Pharmaceuticals Pvt Ltd
βΉ20.79/tablet sr
18% cheaper
Epalpex-M SR Tablet
Shilpex Pharmysis
βΉ26.25/tablet sr
4% costlier
βΉ31.2/tablet sr
24% costlier
Quick tips
Epalrica-M Tablet SR
- Take it only as per the dose and duration prescribed by your doctor.Β
- Adherence to antidiabetic therapy can delay the onset of or prevent diabetic nerve disease.
- Inform your doctor if you have:
- Cut or sore on your feet that is infectious or not healing
- Burning or tingling sensation in arm or feet that hamper your routine activities
- Trouble in digestion, urination, or sexual functioning
- Dizziness
- To prevent diabetic nerve pain, wear proper footwear and examine your feet every day to detect lesions early.
- Monitor your blood sugar level regularly.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
User feedback
Patients taking Epalrica-M Tablet SR
Once A Day
91%
Twice A Day
9%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Sharma SR, Sharma N. Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective. Ann Indian Acad Neurol. 2008;11(4):231-35. [Accecssed 08 Apr. 2019] (online) Available from:
- National Institues of Health. Vitamin B12. [Accessed 08 Apr. 2019] (online) Available from:
- Hotta N, Akanuma Y, Kawamori R, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care. 2006;29(7):1538-44. [Accessed 08 Apr. 2019] (online) Available from:
Marketer details
Name: Ordain Health Care Global Pvt Ltd
Address: Exeltis - Ordain Health Care Global Pvt Ltd , Khivraj Complex - II, 4th Floor, No: 480, Anna Salai, Nandanam, Chennai - 600 035, Tamil Nadu, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
19 people bought this recentlyMRP
βΉ252.07
Inclusive of all taxes
10.0 tablet sr in 1 strip
SOLD OUT